Precision BioSciences, Inc.
DTIL
$6.86
$0.091.33%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -68.31% | 263,007.69% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -68.31% | 263,007.69% | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -68.31% | 263,007.69% | |||
| SG&A Expenses | -5.93% | -9.74% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -8.22% | 4.91% | |||
| Operating Income | -172.55% | 160.52% | |||
| Income Before Tax | -195.81% | 188.41% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -195.81% | 188.41% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -191.60% | 192.47% | |||
| EBIT | -172.55% | 160.52% | |||
| EBITDA | -168.28% | 163.26% | |||
| EPS Basic | -170.84% | 157.36% | |||
| Normalized Basic EPS | -160.91% | 156.05% | |||
| EPS Diluted | -171.43% | 156.99% | |||
| Normalized Diluted EPS | -161.29% | 155.71% | |||
| Average Basic Shares Outstanding | 29.31% | 61.20% | |||
| Average Diluted Shares Outstanding | 28.49% | 62.22% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||